IL37 and pulmonary fibrosis: In the context of respiratory diseases, IL-37 plays a pivotal role, utilizing its anti-inflammatory and immune-modulating capabilities to effectively alleviate asthma symptoms (83, 84), reduce inflammation caused by infections (85), inhibit the growth of lung cancer (82), and mitigate the progression of pulmonary fibrosis (86, 87).